Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Biohaven Ltd (BHVN)

Biohaven Ltd (BHVN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Biohaven Ltd 215 CHURCH STREET NEW HAVEN CT 06510 USA

www.biohaven.com Employees: 256 P: 203-404-0410

Sector:

Medical

Description:

Biohaven Ltd. is a clinical-stage biopharmaceutical company. It focuses on discovering and developing therapies for patients with debilitating neurological and neuropsychiatric diseases principally in the United States. Biohaven Ltd., formerly known as BIOHAVEN PHARM, is based in New Haven, Connecticut.

Key Statistics

Overview:

Market Capitalization, $K 1,253,323
Enterprise Value, $K 1,154,193
Shares Outstanding, K 105,855
Annual Sales, $ 0 K
Annual Net Income, $ -846,420 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -173,440 K
EBIT, $ -792,570 K
EBITDA, $ -784,710 K
60-Month Beta 1.14
% of Insider Shareholders 14.60%
% of Institutional Shareholders 88.78%
Float, K 90,400
% Float 85.40%
Short Interest 17,005
Short Float 16.06%
Short Volume Ratio 0.37

Growth:

1-Year Return -70.73%
3-Year Return -35.79%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 14.94%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.64 on 11/10/25
Next Earnings Date 03/02/26
Earnings Per Share ttm -7.60
EPS Growth vs. Prev Qtr 15.46%
EPS Growth vs. Prev Year 3.53%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

BHVN Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -389.88%
Return-on-Assets % -153.44%
Profit Margin % 0.00%
Debt/Equity -15.63
Price/Sales N/A
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.16
Interest Coverage -8.48
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar